PDL BioPharma, Inc. Operating Income Growth

Operating Income Growth of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating Income Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Operating Income Growth for the quarter ending June 29, 2020 was -48.68% (a -83.09% decrease compared to previous quarter)
  • Year-over-year quarterly Operating Income Growth decreased by -34.48%
  • Annual Operating Income Growth for 2019 was -97.28% (a -22.86% decrease from previous year)
  • Annual Operating Income Growth for 2018 was -126.11% (a -353.49% decrease from previous year)
  • Annual Operating Income Growth for 2017 was 49.75% (a -165.04% decrease from previous year)
  • Twelve month Operating Income Growth ending June 29, 2020 was -342.55% (a 258.09% increase compared to previous quarter)
  • Twelve month trailing Operating Income Growth decreased by -333.07% year-over-year
Trailing Operating Income Growth for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
-342.55% -95.66% -97.28% 146.97%
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating Income Growth of PDL BioPharma, Inc.

Most recent Operating Income Growthof PDLI including historical data for past 10 years.

Interactive Chart of Operating Income Growth of PDL BioPharma, Inc.

PDL BioPharma, Inc. Operating Income Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 -48.68% -287.83%
2019 -373.98% -74.3% 92.6% -291.5% -97.28%
2018 12.13% 12.63% -210.95% -76.81% -126.11%
2017 489.59% -0.1% 912.66% -80.16% 49.75%
2016 -104.75% -71.89% -91.47% -34.33% -76.49%
2015 62.59% -26.9% -16.17% 7.43% 0.74%
2014 -7.89% 72.25% 9.94% 56.18% 28.09%
2013 27.38% 15.92% 17.37% 20.26% 20.0%
2012 24.54% -0.28% 2.03% -9.23% 3.41%
2011 339.16% 5.94% 6.12% 47.3% 62.83%
2010 -153.91% 13.81% -7.28% -28.96%

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.